The Company recently reported a major expansion in retail distribution, with one national pharmacy chain nearly doubling the number of stores carrying GlucoDown® from approximately 1,250 locations to roughly 2,500 locations nationwide. In response to the broader retail footprint, Glucose Health increased its consumer advertising investment during April and May, specifically directing consumers to participating pharmacy locations where GlucoDown® is available.
Glucose Health continues to experience strong year-over-year momentum within the national pharmacy channel, as evidenced by recent sales data. During the first 24 weeks of 2026, the Company shipped more than 120% of the total GlucoDown® volume delivered to a major national pharmacy retailer during all of 2025. Another national drug store chain in the retail pharmacy space has recorded a sales increase of 135.7% for the most recent period from January 1, 2026, through June 6, 2026 versus the same period in 2025. Comparing numbers year-over-year, for the period from August 31, 2025, through June 6, 2026, revenues are up 193%.
Management believes the combination of expanded distribution and targeted consumer marketing is contributing to increased product demand and stronger replenishment orders from retail partners. The company believes that the increase of these two factors serves to underscore increasing demand and accelerating product adoption at retail.
"Our ...
